David Chain is currently the Director of Translational Proteomics at AstraZeneca, where they also hold the position of Associate Director leading AI Digital Imaging and Cell Enrichment in Oncology R&D. They previously served as a Research Investigator in Molecular Histology and Applied Imaging at Sanofi Genzyme from 2012 to 2018 and as a Scientist in Molecular Pathology at sanofi-aventis from 2000 to 2012. Chain's academic journey includes a Ph.D. in Nanomedicine and Clinical Informatics from Rutgers University, expected in 2024, and a Master of Science in Clinical Trial Sciences, with a perfect GPA, which they earned in 2015 from Rutgers University-New Brunswick. They also pursue a Bachelor of Pharmacy in Pharmaceutical Sciences at Rutgers University College of Pharmacy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices